Changing European hemp policy

Lorenza Romanese, Managing Director of the European Industrial Hemp Association, speaks with HEQ about the benefits of hemp and its derivatives and the need for further policy change.

In early February, the European Commission announced that it had added CBD, which is naturally derived from the hemp plant to CosIng (cosmetic ingredients), to its list of approved cosmetic ingredients. This was the latest step in a series of international moves indicating growing acceptance of the drug, following a ruling by the European Court of Justice in November that CBD is ‘not a narcotic’ and a December vote by the United Nations to remove cannabis from its Schedule 1 list of dangerous drugs.


Cannabis in Greece: The Nevada of Europe?

A new draft law currently on the desk of the Ministry of Development and Investment is likely to change the equation in not only Greece itself on the cannabis question, but the rest of Europe.


Hexo Stock: Should Investors Buy As This Cannabis Player Expands Into Europe?

marijuana plants

Canadian legalization of cannabis has resulted in an absolute boom in pot stocks in recent years. Indeed, this past year has been no different. Canadian-listed cannabis stocks have more than doubled from March 2020 lows.

That’s a great thing for cannabis investors looking for a move with tonnes of upside. However, some analysts believe these moves have resulted in cannabis valuations getting ahead of their valuations right now.


Is Europe’s Cannabis Sector Poised for Take Off?

marijuana buds

2021 could be a critical year for the rapidly growing cannabis industry. As public support for the legalization of cannabis continues to grow, what does that mean for the regulation of cannabis’s various industry segments — medical, recreational, hemp and CBD wellness markets?

On Altamar’s latest podcast episode, Altamar hosts Peter Schechter and Muni Jensen discuss the future of the cannabis industry with Benjamin-Alexandre Jeanroy. Jeanroy is CEO of Augur Associates, a Paris-based consulting firm focused entirely on the sustainable cannabis industry, and co-founder of Echo Citoyen, a think tank that works on drug policy reform in France. Previously, he was a consultant for the United Nations Office on Drugs and Crime.


Medicinal cannabis policy and research in Europe

testing dish with green liquid with marijuana leaf

HEQ speaks with Medicinal Cannabis Europe about the European medical cannabis landscape.

The European medical cannabis space is evolving, with more and more EU Member States taking an increasingly favourable view of the clinical benefits of cannabis and its derivatives. Medicinal Cannabis Europe was launched in 2018, with the remit of ensuring fair, equal access to medical cannabis products for patients and establishing a harmonised policy framework at the EU level.


Aussie cannabis firms go capital light as they roll into Europe

marijuana plants

A handful of small, young Australian firms are taking a chance on Europe in spite of the region's diverse markets, hopeful that a capital-light investment strategy will diminish their risks.

Europe could be a hard market to crack as regulations vary by country, but favourable rulings for medical marijuana and potential demand are promising factors. The companies reckon that establishing an early base there and working with European partners will help them better negotiate different markets and steal a march on larger North American rivals.

Cann Group and MGC Pharmaceuticals are among many firms that have pushed into Europe, recently signing partnerships to distribute medical marijuana products and also exploring a dual-listing in the region.


Mirror, Mirror On The Wall – Which Is The Best CBD Cosmetic Regulation Of Them All?

a board of cannabis bars and beauty goods

There is no way to talk about the use of any kind of cannabis in Europe without running into a mouthful of long, number-delineated if not hyphenated directives. Cannabis Sativa L is, ultimately, a plant with many uses by humans. Every one of those applications, but particularly consumables, carries its own rules. 

The cosmetics space is no exception. 

There is good news though. Critical pieces of such regulation have now been changed over the last several months in the EU, and it will have a huge impact on the development of the vertical across the region.


EU Adds CBD To Its List Of Legal Cosmetic Ingredients

person using cbd with make up

Up until now, only synthetic CBD was expressly allowed as a cosmetic ingredient in the European Union’s database.

On February 4, the European Union (EU)’s Directorate-General for Internal Market, Industry, Entrepreneurship and SMEs added cannabidiol (CBD) “derived from extract or tincture or resin of cannabis” as a legal cosmetic ingredient to its CosIng guidelines.

CosIng is a database of cosmetic regulations that expressly provides for authorized and unlawful ingredients and sets forth their particular purposes and functions.


The European Union Is Going To Be A Major Driving Force For CBD In 2021

the eu flag, made up of blue marijuana leaves

Read entire article at Technical 420

With 2020 coming to a close in less than two weeks, we want to highlight one of the most significant themes of the year as it relates to the cannabis industry.

The theme is the European Union (EU) and we believe that the continent made significant strides in 2020. Although the EU cannabis market recorded impressive growth when compared to 2019, the growth came in below broker-dealer expectations and we believe that this put pressure on the companies that are highly focused on it.


Prohibition Partners' Top Ten Trends for 2021

image of 2021 spelled out in moon images



As 2020 comes to a close, Prohibition Partners' international team of analysts, consultants and thought-leaders have come together to analyse the top trends set to define the cannabis industry in 2021 and beyond. 

From the impact of Brexit and COVID-19 to the rapidly developing legislation in the US and Latin America, find out what is in store for one of the world's most dynamic sectors.

1. The Impact of COVID-19

The COVID-19 pandemic has had a profound impact on the global economy as lockdown measures, and economic uncertainty caused many companies, including those in the cannabis industry, to downsize and re-evaluate strategies. COVID-19 undoubtedly raises opportunities for the cannabis industry at large.


Subscribe to RSS - Europe